BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 33933071)

  • 1. The extracellular HDAC6 ZnF UBP domain modulates the actin network and post-translational modifications of Tau.
    Balmik AA; Sonawane SK; Chinnathambi S
    Cell Commun Signal; 2021 May; 19(1):49. PubMed ID: 33933071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDAC6 ZnF UBP as the Modifier of Tau Structure and Function.
    Balmik AA; Chidambaram H; Dangi A; Marelli UK; Chinnathambi S
    Biochemistry; 2020 Dec; 59(48):4546-4562. PubMed ID: 33237772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inter-relationship of Histone Deacetylase-6 with Tau-cytoskeletal organization and remodeling.
    Balmik AA; Chinnathambi S
    Eur J Cell Biol; 2022 Apr; 101(2):151202. PubMed ID: 35092942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase-6 modulates Tau function in Alzheimer's disease.
    Qureshi T; Chinnathambi S
    Biochim Biophys Acta Mol Cell Res; 2022 Aug; 1869(8):119275. PubMed ID: 35452751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into the non-enzymatic function of HDAC6.
    Zhu Y; Feng M; Wang B; Zheng Y; Jiang D; Zhao L; Mamun MAA; Kang H; Nie H; Zhang X; Guo N; Qin S; Wang N; Liu H; Gao Y
    Biomed Pharmacother; 2023 May; 161():114438. PubMed ID: 37002569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase 6 interacts with the microtubule-associated protein tau.
    Ding H; Dolan PJ; Johnson GV
    J Neurochem; 2008 Sep; 106(5):2119-30. PubMed ID: 18636984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudophosphatase MK-STYX Alters Histone Deacetylase 6 Cytoplasmic Localization, Decreases Its Phosphorylation, and Increases Detyrosination of Tubulin.
    Cao Y; Banks DA; Mattei AM; Riddick AT; Reed KM; Zhang AM; Pickering ES; Hinton SD
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dynamics of zinc-finger ubiquitin binding domains: a comparative study of histone deacetylase 6 and ubiquitin-specific protease 5.
    Dos Santos Passos C; Simões-Pires CA; Carrupt PA; Nurisso A
    J Biomol Struct Dyn; 2016 Dec; 34(12):2581-2598. PubMed ID: 26619262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of Unanchored Polyubiquitin Chains from Influenza Virions.
    Miyake Y; Matthias P; Yamauchi Y
    Methods Mol Biol; 2018; 1836():329-342. PubMed ID: 30151581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytes.
    Noack M; Leyk J; Richter-Landsberg C
    Glia; 2014 Apr; 62(4):535-47. PubMed ID: 24464872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SQSTM1/p62 interacts with HDAC6 and regulates deacetylase activity.
    Yan J; Seibenhener ML; Calderilla-Barbosa L; Diaz-Meco MT; Moscat J; Jiang J; Wooten MW; Wooten MC
    PLoS One; 2013; 8(9):e76016. PubMed ID: 24086678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttranslational modification and beyond: interplay between histone deacetylase 6 and heat-shock protein 90.
    Liu P; Xiao J; Wang Y; Song X; Huang L; Ren Z; Kitazato K; Wang Y
    Mol Med; 2021 Sep; 27(1):110. PubMed ID: 34530730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline.
    Trzeciakiewicz H; Ajit D; Tseng JH; Chen Y; Ajit A; Tabassum Z; Lobrovich R; Peterson C; Riddick NV; Itano MS; Tripathy A; Moy SS; Lee VMY; Trojanowski JQ; Irwin DJ; Cohen TJ
    Nat Commun; 2020 Nov; 11(1):5522. PubMed ID: 33139698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.
    Fan SJ; Huang FI; Liou JP; Yang CR
    Cell Death Dis; 2018 May; 9(6):655. PubMed ID: 29844403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An acetylation-phosphorylation switch that regulates tau aggregation propensity and function.
    Carlomagno Y; Chung DC; Yue M; Castanedes-Casey M; Madden BJ; Dunmore J; Tong J; DeTure M; Dickson DW; Petrucelli L; Cook C
    J Biol Chem; 2017 Sep; 292(37):15277-15286. PubMed ID: 28760828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of WW domain-containing oxidoreductase induces Tau phosphorylation in vitro. A potential role in Alzheimer's disease.
    Sze CI; Su M; Pugazhenthi S; Jambal P; Hsu LJ; Heath J; Schultz L; Chang NS
    J Biol Chem; 2004 Jul; 279(29):30498-506. PubMed ID: 15126504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OCT4B-190 protects against ischemic stroke by modulating GSK-3β/HDAC6.
    Chen Y; Wu Z; Zhu X; Zhang M; Zang X; Li X; Xu Y
    Exp Neurol; 2019 Jun; 316():52-62. PubMed ID: 30981804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular α-synuclein leads to microtubule destabilization via GSK-3β-dependent Tau phosphorylation in PC12 cells.
    Gąssowska M; Czapski GA; Pająk B; Cieślik M; Lenkiewicz AM; Adamczyk A
    PLoS One; 2014; 9(4):e94259. PubMed ID: 24722055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein aggregates are recruited to aggresome by histone deacetylase 6 via unanchored ubiquitin C termini.
    Ouyang H; Ali YO; Ravichandran M; Dong A; Qiu W; MacKenzie F; Dhe-Paganon S; Arrowsmith CH; Zhai RG
    J Biol Chem; 2012 Jan; 287(4):2317-27. PubMed ID: 22069321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylation as a major determinant to microtubule-dependent autophagy: Relevance to Alzheimer's and Parkinson disease pathology.
    Esteves AR; Palma AM; Gomes R; Santos D; Silva DF; Cardoso SM
    Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):2008-2023. PubMed ID: 30572013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.